SAMPAOLESI, MAURILIO
 Distribuzione geografica
Continente #
NA - Nord America 7.394
AS - Asia 5.651
EU - Europa 4.304
SA - Sud America 799
Continente sconosciuto - Info sul continente non disponibili 255
AF - Africa 186
OC - Oceania 15
Totale 18.604
Nazione #
US - Stati Uniti d'America 7.246
CN - Cina 2.828
SG - Singapore 1.229
IE - Irlanda 1.009
UA - Ucraina 618
BR - Brasile 604
HK - Hong Kong 587
FI - Finlandia 494
VN - Vietnam 478
DE - Germania 472
RU - Federazione Russa 411
IT - Italia 298
FR - Francia 279
GB - Regno Unito 244
SE - Svezia 209
IN - India 132
BE - Belgio 95
ZA - Sudafrica 91
BD - Bangladesh 72
CA - Canada 70
AR - Argentina 61
MX - Messico 48
IQ - Iraq 45
TR - Turchia 44
EC - Ecuador 41
NL - Olanda 36
PL - Polonia 31
ID - Indonesia 29
JP - Giappone 24
VE - Venezuela 24
PK - Pakistan 23
ES - Italia 22
UZ - Uzbekistan 21
SA - Arabia Saudita 18
CO - Colombia 16
KE - Kenya 16
TN - Tunisia 16
MA - Marocco 15
EG - Egitto 14
PY - Paraguay 14
AU - Australia 13
CL - Cile 13
CZ - Repubblica Ceca 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
MY - Malesia 11
PE - Perù 11
PH - Filippine 11
DZ - Algeria 9
IR - Iran 9
LT - Lituania 9
AT - Austria 8
AZ - Azerbaigian 8
EU - Europa 8
CH - Svizzera 7
KZ - Kazakistan 7
UY - Uruguay 7
PT - Portogallo 6
BO - Bolivia 5
CR - Costa Rica 5
EE - Estonia 5
JM - Giamaica 5
KG - Kirghizistan 5
KR - Corea 5
RO - Romania 5
SN - Senegal 5
TH - Thailandia 5
ET - Etiopia 4
GR - Grecia 4
GT - Guatemala 4
LV - Lettonia 4
MU - Mauritius 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
LK - Sri Lanka 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
AM - Armenia 1
Totale 18.335
Città #
Dublin 1.009
Chandler 938
Jacksonville 786
San Jose 766
Ashburn 677
Nanjing 642
Singapore 626
Hong Kong 576
Dallas 416
Beijing 373
Boardman 340
Nanchang 270
Princeton 215
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 180
Los Angeles 177
Lauterbourg 176
Ho Chi Minh City 174
Changsha 163
Ann Arbor 157
Jiaxing 157
Helsinki 141
Hangzhou 110
Tianjin 106
Hanoi 102
Buffalo 92
Milan 88
Johannesburg 80
Munich 67
Shanghai 64
Moscow 63
Woodbridge 62
Redondo Beach 60
New York 57
Pavia 54
Verona 51
Council Bluffs 49
Orem 45
São Paulo 45
Santa Clara 43
Brussels 41
Herent 33
Norwalk 31
Chennai 29
Seattle 29
Turku 29
Toronto 27
Brooklyn 26
Fairfield 26
Guangzhou 26
Warsaw 26
Frankfurt am Main 25
Baghdad 23
Kunming 23
Pune 23
The Dalles 23
Da Nang 22
Houston 22
Montreal 22
Chicago 21
Washington 21
Des Moines 20
Falkenstein 20
Leuven 20
Tokyo 20
San Francisco 18
Tashkent 18
Amsterdam 16
Auburn Hills 15
Denver 15
Jinan 15
Mumbai 15
Nuremberg 15
Phoenix 15
Rio de Janeiro 15
Ankara 14
Brasília 14
Falls Church 14
London 14
Manchester 14
Nairobi 14
Poplar 14
Quito 14
Biên Hòa 13
Haiphong 13
Lahore 13
Mexico City 13
Stockholm 13
Zhengzhou 13
Belo Horizonte 12
Boston 12
Guayaquil 12
Amman 11
Ningbo 11
Redwood City 11
Atlanta 10
Caracas 10
Totale 12.067
Nome #
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 188
Electromagnetic fields influence the gene expression of SAOS-2 cell line 173
Evaluation of energy expenditure in athletes practising horseback riding 171
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 169
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 164
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 161
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 157
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 155
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 155
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 153
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 149
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 146
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 144
Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model 141
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 132
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 131
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 130
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 127
Adult Stem Cells and Skeletal Muscle Regeneration 127
Gene signature of muscle hypertrophy 127
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 125
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 123
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 121
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 121
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 121
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 119
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 119
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 118
Cell therapy strategies and improvements for muscular dystrophy. 117
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 115
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 114
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 114
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 114
Bedside to bench: a look at experimental research with a clinical trial checklist 112
In vitro and in vivo tissue engineering approaches in regenerative medicine 112
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 112
Evaluation of the effects of a dynamic culture on osteogenic differentiation of oral-periosteal cells grown on PLGA sponges 111
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 110
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 110
Aging affects the in vivo regenerative potential of human mesoangioblasts 110
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 110
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 108
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 108
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 107
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 107
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 107
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 107
The effects of micro-grafts in the treatment of androgenetic alopecia 106
Brief Communication Arising 105
Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells 103
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 103
About Mesoangioblasts 102
Magic-F1 transgene cooperates with Pax 3 during early myogenesis to induce muscular hypertrophy 102
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 102
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 101
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 101
Alteration of cardiac progenitor cell potency in GRMD dogs 101
Cardiac development and remodelling in Magic-F1 transgenic mice 101
Guide cells support muscle regeneration and affect neuro-muscular junction organization 101
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 100
Inducing muscular hypertrophy by recombinant proteins 100
Poly-l-Lactic Acid Nanofiber–Polyamidoamine Hydrogel Composites: Preparation, Properties, and Preliminary Evaluation as Scaffolds for Human Pluripotent Stem Cell Culturing 100
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation 100
In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly-L-lysine-treated titanium-6-aluminium-4-vanadium 97
Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery 97
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 96
Skeletal muscle engineering: scaffolds and recombinant proteins 96
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 95
Magic F-1: a new engineered protein involved in muscular hypertrophy and regeneration 95
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives 95
Hamster cardiomyocytes: a model of myocardial regeneration? 94
The investigation of the effects of autologous micrografts in the process of wound healing 94
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 93
Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. 93
Muscle hypertrophy and vascularization induction using recombinant proteins 93
Skeletal muscle regenerative approach combining stem cells and 3D bioprinting 93
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 92
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 92
New therapies for muscular dystrophy: cautious optimism. 92
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 91
Terapia cellulare mesenchimale nella distrofia muscolare 90
Exploring wound-healing genomic machinery with a network-based approach 90
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 89
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 88
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 88
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 88
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 88
Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo 88
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells 88
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 88
Stem Cell homing and regulation: new insights from muscular dystrophy 87
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 87
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 87
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 86
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 86
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 86
Welcome to Cardiovascular Research in 2015 86
Mononucleated Cells to Regenerate Skeletal Muscle Syncytial Tissues 86
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 85
Stem cell-niche and lysosomal cathepsins 85
Totale 11.044
Categoria #
all - tutte 80.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022841 0 6 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/20252.473 38 242 116 78 40 87 125 170 559 71 287 660
2025/20266.123 473 485 757 748 695 223 1.124 248 459 491 291 129
2026/202788 81 7 0 0 0 0 0 0 0 0 0 0
Totale 18.604